Wrighton SA - Search Results

1

Tissue distribution and interindividual variation in human UDP-glucuronosyltransferase activity: relationship between UGT1A1 promoter genotype and variability in a liver bank.

Fisher MB, Vandenbranden M, Findlay K, Burchell B, Thummel KE, Hall SD, Wrighton SA. Fisher MB, et al. Among authors: wrighton sa. Pharmacogenetics. 2000 Nov;10(8):727-39. doi: 10.1097/00008571-200011000-00007. Pharmacogenetics. 2000. PMID: 11186135

2

Interaction of human liver cytochromes P450 in vitro with LY307640, a gastric proton pump inhibitor.

VandenBranden M, Ring BJ, Binkley SN, Wrighton SA. VandenBranden M, et al. Among authors: wrighton sa. Pharmacogenetics. 1996 Feb;6(1):81-91. doi: 10.1097/00008571-199602000-00007. Pharmacogenetics. 1996. PMID: 8845864

3

Examination of purported probes of human CYP2B6.

Ekins S, VandenBranden M, Ring BJ, Wrighton SA. Ekins S, et al. Among authors: wrighton sa. Pharmacogenetics. 1997 Jun;7(3):165-79. doi: 10.1097/00008571-199706000-00001. Pharmacogenetics. 1997. PMID: 9241656

4

Human cytochrome P450 3A (CYP3A) mediated midazolam metabolism: the effect of assay conditions and regioselective stimulation by alpha-naphthoflavone, terfenadine and testosterone.

Mäenpää J, Hall SD, Ring BJ, Strom SC, Wrighton SA. Mäenpää J, et al. Among authors: wrighton sa. Pharmacogenetics. 1998 Apr;8(2):137-55. Pharmacogenetics. 1998. PMID: 10022752

5

In vitro glucuronidation using human liver microsomes and the pore-forming peptide alamethicin.

Fisher MB, Campanale K, Ackermann BL, VandenBranden M, Wrighton SA. Fisher MB, et al. Among authors: wrighton sa. Drug Metab Dispos. 2000 May;28(5):560-6. Drug Metab Dispos. 2000. PMID: 10772635

6

Differential modulation of UDP-glucuronosyltransferase 1A1 (UGT1A1)-catalyzed estradiol-3-glucuronidation by the addition of UGT1A1 substrates and other compounds to human liver microsomes.

Williams JA, Ring BJ, Cantrell VE, Campanale K, Jones DR, Hall SD, Wrighton SA. Williams JA, et al. Among authors: wrighton sa. Drug Metab Dispos. 2002 Nov;30(11):1266-73. doi: 10.1124/dmd.30.11.1266. Drug Metab Dispos. 2002. PMID: 12386134

7

Characterization by liquid chromatography-nuclear magnetic resonance spectroscopy and liquid chromatography-mass spectrometry of two coupled oxidative-conjugative metabolic pathways for 7-ethoxycoumarin in human liver microsomes treated with alamethicin.

Fisher MB, Jackson D, Kaerner A, Wrighton SA, Borel AG. Fisher MB, et al. Among authors: wrighton sa. Drug Metab Dispos. 2002 Mar;30(3):270-5. doi: 10.1124/dmd.30.3.270. Drug Metab Dispos. 2002. PMID: 11854144

8

Isolation and characterization of human liver cytochrome P450 2C19: correlation between 2C19 and S-mephenytoin 4'-hydroxylation.

Wrighton SA, Stevens JC, Becker GW, VandenBranden M. Wrighton SA, et al. Arch Biochem Biophys. 1993 Oct;306(1):240-5. doi: 10.1006/abbi.1993.1506. Arch Biochem Biophys. 1993. PMID: 8215410

9

Bimodal distribution of renal cytochrome P450 3A activity in humans.

Haehner BD, Gorski JC, Vandenbranden M, Wrighton SA, Janardan SK, Watkins PB, Hall SD. Haehner BD, et al. Among authors: wrighton sa. Mol Pharmacol. 1996 Jul;50(1):52-9. Mol Pharmacol. 1996. PMID: 8700118

10

The human drug metabolizing cytochromes P450.

Wrighton SA, VandenBranden M, Ring BJ. Wrighton SA, et al. J Pharmacokinet Biopharm. 1996 Oct;24(5):461-73. doi: 10.1007/BF02353474. J Pharmacokinet Biopharm. 1996. PMID: 9131485 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

180 results

Search Page